Research Triangle Park.

PositionTriangle

RESEARCH TRIANGLE PARK -- Talecris Biotherapeutics, which makes drugs and other products from blood plasma, agreed to be acquired by Australian rival CSL for about $3.1 billion. It employs about 2,100 at its headquarters and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT